Today: 30 June 2026
Sandisk stock today: SNDK slips after-hours as company sets Jan. 29 earnings date

Sandisk stock today: SNDK slips after-hours as company sets Jan. 29 earnings date

NEW YORK, December 30, 2025, 17:33 ET — After-hours

  • Sandisk shares were down 1.6% at $240.22 in after-hours trading.
  • The company set its fiscal second-quarter earnings call for Jan. 29, 2026.
  • Micron and Western Digital were also lower, while the semiconductor ETF was little changed.

Sandisk Corp (SNDK) slipped in after-hours trading on Tuesday after the company set Jan. 29 for its next earnings report. Shares were last down 1.6% at $240.22.

The calendar update lands as Sandisk heads into the final two sessions of the year with a stock that has been among 2025’s biggest S&P 500 gainers. That has kept traders on alert for outsized swings around even routine company updates.

Investors use Sandisk’s results as a read on demand and pricing for NAND flash — the memory used in storage devices such as solid-state drives (SSDs). The company has highlighted data-center demand as a key driver, alongside consumer and client markets.

Sandisk said the fiscal second-quarter earnings conference call is scheduled for Thursday, Jan. 29, 2026, at 1:30 p.m. Pacific time (4:30 p.m. ET), with a live webcast and replay available on its investor site.

During Tuesday’s session, the stock traded between $236.64 and $247.26, with roughly 5.7 million shares changing hands. The S&P 500 and Nasdaq were down 0.14% and 0.24%, respectively.

Peer moves were subdued in late trade, with Micron down 0.6% and Western Digital off about 2.0%, while the iShares Semiconductor ETF slipped 0.1%.

Sandisk, based in Milpitas, California, sells NAND-flash storage products including SSDs, removable cards and USB drives. It became a standalone, publicly traded company after separating from Western Digital in February.

The stock’s sharp 2025 run — up about 594% as of Kiplinger’s latest tally — has also made it sensitive to profit-taking and year-end portfolio rebalancing.

Sandisk last reported quarterly results in November, when it posted first-quarter revenue of $2.31 billion and non-GAAP (adjusted) earnings of $1.22 per share. It forecast fiscal second-quarter revenue of $2.55 billion to $2.65 billion and non-GAAP earnings of $3.00 to $3.40 per share.

“Customers are turning to Sandisk for our leading technology and products, which are exceptionally well positioned at a time when demand is strengthening,” CEO David Goeckeler said in that release. Business Wire

For the Jan. 29 report, investors will focus on data-center momentum, including progress with hyperscalers — large cloud providers — and on the ramp of BiCS8, Sandisk’s latest generation 3D flash technology. BiCS8 accounted for 15% of total bits shipped in the first quarter, the company said.

Traders are also watching near-term technical levels after Tuesday’s swing, with support near the session low of $236.64 and resistance around the $247.26 high.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386
Previous Story

Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop